Cargando…
MDA5-positive dermatomyositis: an uncommon entity in Europe with variable clinical presentations
Clinically amyopathic dermatomyositis (CADM), described almost 50 years ago, is defined on the basis of still not validated criteria and characterized by skin findings almost without muscle weakness. Autoantibodies directed against the cytosolic pathogen sensor MDA5 (CADM 140) can mark this subtype...
Autores principales: | Parronchi, Paola, Radice, Anna, Palterer, Boaz, Liotta, Francesco, Scaletti, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637993/ https://www.ncbi.nlm.nih.gov/pubmed/26557046 http://dx.doi.org/10.1186/s12948-015-0031-y |
Ejemplares similares
-
Editorial: Anti-MDA5-Positive Dermatomyositis
por: Gono, Takahisa, et al.
Publicado: (2022) -
Anti-MDA5 antibody-positive dermatomyositis presenting as unilateral eyelid edema
por: Chen, Lauren, et al.
Publicado: (2020) -
Seasonal Effect on Disease Onset and Presentation in Anti-MDA5 Positive Dermatomyositis
por: So, Ho, et al.
Publicado: (2022) -
Hypomyopathic Dermatomyositis Presenting with Idiopathic CD4 T-lymphocytopenia and Delayed Anti-MDA5 Positivity
por: Mijares, Maria C, et al.
Publicado: (2019) -
An uncommon presentation of a sinister entity
por: Naidu, Krishanth, et al.
Publicado: (2020)